Literature DB >> 3335208

Localization of 7B2, neuromedin B, and neuromedin U in specific cell types of rat, mouse, and human pituitary, in rat hypothalamus, and in 30 human pituitary and extrapituitary tumors.

J H Steel1, S Van Noorden, J Ballesta, S J Gibson, M A Ghatei, J Burrin, U Leonhardt, J Domin, S R Bloom, J M Polak.   

Abstract

The distributions of three novel peptides, 7B2, neuromedin B, and neuromedin U, in rat, mouse, and human pituitaries, rat hypothalamus, and 30 human pituitary tumors were investigated with immunocytochemistry. Immunoreactivity for 7B2 was present in rat, mouse, and human gonadotropes, in intermediate lobe cells and posterior lobe nerve fibers in rats and mice, in rat hypothalamus (particularly in the median eminence), and in eight human pituitary gonadotropinomas. In gonadectomized rats, larger, more numerous LH beta- and 7B2-immunoreactive gonadotropes were seen than in controls. Extractable 7B2-like immunoreactivity was elevated but not significantly so in gonadectomized rat pituitaries [males: castrated, 37.4 +/- 4.3 (mean +/- SE); controls, 26.9 +/- 4.3; females: ovariectomized, 27.2 +/- 2.7; controls, 19.1 +/- 2.2 pmol/gland]. Neuromedin B immunoreactivity was found in normal rat and mouse thyrotropes and weakly in "thyroidectomy" cells in hypothyroid rats, in which extractable pituitary neuromedin B was significantly depleted (thyroidectomized, 87.0 +/- 14.0; methimazole-treated, 82.0 +/- 11.4; control, 230.7 +/- 25.6 fmol/gland). Hyperthyroid rat pituitaries showed increased TSH beta and neuromedin B immunoreactivities and neuromedin B content (TRH-treated, 385.2 +/- 30.2; T4-treated, 352.6 +/- 20.2; control, 230.7 +/- 25.6 fmol/gland). Neuromedin U immunoreactivity occurred in corticotropes of all species, in rat and mouse intermediate lobe, and throughout the rat hypothalamus, with immunoreactive cell bodies in the arcuate nucleus. Neuromedin U-immunoreactive cells were present in six of six human pituitary and five of six human extrapituitary corticotropinomas. In adrenalectomized rats, corticotropes were larger and more numerous than in controls, but extractable anterior pituitary neuromedin U-like immunoreactivity was not raised (adrenalectomized, 3.30 +/- 0.45; control, 3.32 +/- 0.27 pmol/gland). Our findings suggest that 7B2, neuromedin B, and neuromedin U may be involved in pituitary function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335208     DOI: 10.1210/endo-122-1-270

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

1.  Combined use of in situ hybridisation and immunocytochemistry for the investigation of prolactin gene expression in immature, pubertal, pregnant, lactating and ovariectomised rats.

Authors:  J H Steel; Q Hamid; S Van Noorden; P Jones; P Denny; J Burrin; S Legon; S R Bloom; J M Polak
Journal:  Histochemistry       Date:  1988

Review 2.  Neuroendocrine secretory protein 7B2: structure, expression and functions.

Authors:  M Mbikay; N G Seidah; M Chrétien
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

Review 3.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

4.  Neuromedin S and U.

Authors:  Colleen M Novak
Journal:  Endocrinology       Date:  2009-07       Impact factor: 4.736

Review 5.  Towards a functional significance of peptides and biogenic amines produced by the anterior pituitary.

Authors:  H Houben; D Tilemans; C Denef
Journal:  J Endocrinol Invest       Date:  1990-11       Impact factor: 4.256

6.  Modulation of galanin and neuromedin U-like immunoreactivity in rat corticotropes after alteration of endocrine status.

Authors:  V Cimini; S Van Noorden; C M Timson; J M Polak
Journal:  Cell Tissue Res       Date:  1993-04       Impact factor: 5.249

7.  Peptidylglycine alpha-amidating monooxygenase (PAM) immunoreactivity and messenger RNA in human pituitary and increased expression in pituitary tumours.

Authors:  J H Steel; A Martínez; D R Springall; A M Treston; F Cuttitta; J M Polak
Journal:  Cell Tissue Res       Date:  1994-04       Impact factor: 5.249

8.  Neuromedin U-like immunoreactivity in the thyroid gland of the rat.

Authors:  J Domin; A M Al-Madani; M Desperbasques; A E Bishop; J M Polak; S R Bloom
Journal:  Cell Tissue Res       Date:  1990-04       Impact factor: 5.249

9.  Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats.

Authors:  Jane Gartlon; Philip Szekeres; Mark Pullen; Henry M Sarau; Nambi Aiyar; Usman Shabon; David Michalovich; Klaudia Steplewski; Cathy Ellis; Nabil Elshourbagy; Mark Duxon; Tracey E Ashmeade; David C Harrison; Paul Murdock; Shelagh Wilson; Abdel Ennaceur; Alan Atkins; Christian Heidbreder; Jim J Hagan; A Jackie Hunter; Declan N C Jones
Journal:  Psychopharmacology (Berl)       Date:  2004-06-16       Impact factor: 4.530

10.  Appetite-modifying actions of pro-neuromedin U-derived peptides.

Authors:  David A Bechtold; Tina R Ivanov; Simon M Luckman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-16       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.